Challenges and opportunities in rare tumor research

FHS
July 22, 2024
10:43 am

Ning Li et al., at Chinese Academy of Medical Sciences and Peking Union Medical College, China, provides a comprehensive review on the challenges and opportunities in the field of rare tumor research and management.

FDA chief: AI adoption driven by financial reasons, not patient benefits

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in

November 21, 2024

FDA hands down partial hold for Sun Pharma’s alopecia JAK candidate

Roughly a month after announcing plans to merge several units under Sumitomo Pharma America this July, the drugmaker is making cuts in Massachusetts. Sumitomo Pharma

May 3, 2023

Prenatal exposure to cannabinoids impacts adult health in rats

Scientists who exposed pregnant rats to a synthetic cannabinoid that activates the same receptors in the brain as marijuana detected effects of the drug on

October 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.